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ABSTRACT
With the development of advanced medical technology, a significant proportion of
patients can be cured of many chronic diseases. Because a substantial fraction of patients
have censored information, the standard survival model, such as the proportional hazards
(PH) model cannot capture the cured information of patients. Thus PH mixture cure model
is developed to handle the survival data with potential cured information. A corresponding
sample size formula based on log rank test has been proposed by Wang et al. (2012) and
the probability of death in their formula is only contributed by the control arm. However,
to calculate the sample size and power, the hazard ratio and odds ratio are prespecified,
which can also contribute to increase the accuracy of probability of death, by accounting
for both the control and treatment arm. Therefore, we modify this formula by improving
the estimation of the probability of death based on both the control and treatment arm using
two approaches. The Schoenfeld and Ewell method adjusts the probability of death by
averaging the death from both groups. The modified approach is verified by extensive
simulation under exponential, weibull and lognormal distribution. The performance of the
three methods has been compared under each setting with parametric and nonparametric
estimation. Furthermore, the sample size calculation has been extended to PH mixture cure
model with nonbinary covariates and evaluated by simulation studies. These modifications
have been implemented in the R package and applied to the real data sets.
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CHAPTER 1 INTRODUCTION
In randomized controlled clinical trials with time-to-event endpoints, a sample size
calculation is a very important consideration. Because the main goal in survival analysis is
to distinguish the treatment effect among different groups, the number of patients enrolled
should be adequate for obtaining the conclusion from statistical inference. On the other
hand, excess number of patients may result in waste of resources. Thus developing accurate
and widely used sample size calculation method has attracted more and more interests.

1.1 PROPORTIONAL HAZARDS MODEL
The proportional hazards (PH) model is one of the most popular models in survival
analysis [1, 2]. The PH model can be expressed as

ℎ(𝑡|𝒙) = ℎ0 (𝑡 )exp(𝜷′𝒙)
where ℎ(·) is the hazard function, ℎ0 (·) is the baseline hazard function, 𝒙 is a vector of
covariates and 𝜷 is an unknown vector of coefficients of interest. In the case where 𝒙 = 0,
the hazard function ℎ(𝑡|𝒙) reduces to the baseline hazard function ℎ0 (𝑡).
Under the PH model, the hazard ratio of two subjects is constant over time. For example,
the hazard ratio of two subjects with covariates 𝒙𝟏 and 𝒙𝟐 is calculated as

𝐻𝑅 =

ℎ0 (𝑡)exp(𝜷𝒙𝟏 )
ℎ0 (𝑡)exp(𝜷𝒙𝟐 )

= exp[𝜷(𝒙𝟏 − 𝒙𝟐 )]

which is apparently constant over time. We could interpret the HR (exp[𝜷(𝒙𝟏 − 𝒙𝟐 )]) as
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the relative risk of an individual with risk factor 𝒙𝟏 having the event as compared to an
individual with risk factor 𝒙𝟐 having the event. Particularly, given all other variables at the
same level, when x is a binary indicator variable of control and treatment arm,exp(𝜷) can
be interpreted as the hazard ratio between two arms. Having this nice interpretation, the
PH model is used for investigating the covariate effects on the hazard function.
The proportional hazards model has been widely used in practice due to its easy
estimation through the nonparametric approach. Particularly, there is no need to specify
the baseline hazard function and the MLE approach is approximated by the partial
likelihood. The estimation based on this approach is consistent and satisfies the normal
approximation. Based on the estimated parameter 𝛽 , the survival function can be estimated
nonparametrically. The partial likelihood has been implemented in most statistical software
such as “phreg” in SAS, “coxph” in R, and “stcox” in stata [3],

1.2 SAMPLE SIZE CALCULATION FOR PROPORTIONAL HAZARDS MODEL
Especially for 𝑥 being a binary variable, if letting 𝑥 indicate the treatment effect
(𝑥 = 1for treatment arm and 𝑥 = 0 for control arm), the PH model can be expressed as

ℎ(𝑡|𝑥) = ℎ0 (𝑡 )exp(𝛽0 𝑥)
After adjusting all the other covariates, exp(𝛽0 ) can be interpreted as the risk ratio of an
individual in treatment arm having the event as compared to an individual in control arm
having the event.
Assuming 1 − 𝜃 is the power of statistical test, α is the significance level, and thus
𝑍𝜃 and 𝑍𝛼⁄2 are the 𝜃 and 𝛼 ⁄2 percentiles of the standard normal distribution, respectively;
𝑝 is the proportion of subjects in the treatment arm; 𝛽0 is the log-hazard ratio between
2

treatment and control arms; 𝛿 is the censoring indicator, for which 1 denotes failure and 0
denotes censoring. 𝑃(𝛿 = 1) is the probability of failure. The following sample size
formula based on the standard PH model has been widely used [4, 5],

𝑛=

(𝑍𝜃 +𝑍𝛼⁄2 )2
𝑝(1−𝑝)𝛽02 𝑃(𝛿=1)



(1.1)

The major statistics software can perform sample size and power calculation for
survival studies. In SAS [6], “TWOSAMPLESURVIVAL” statement in the POWER
procedure can compare two survival curves based on log-rank test, using Schoenfeld’s
method [4]. Stata has several “stpower” commands for calculating sample size under
various scenarios. The R package “powerSurvEpi” has several functions to calculate
sample size for Cox PH model with both binary and nonbinary covariates [7]. However,
these software packages have limited options in either the survival distribution function or
the accrual pattern.

1.3 PROPORTIONAL HAZARDS MIXTURE CURE MODEL
As we know, in all the standard survival models, there’s a common assumption,
that all patients will eventually experience the event of interest, which means that when
time is long enough, the survival probability for the population will become 0. However,
with the development of advanced medical technology, many fatal and chronic diseases
are now becoming curable. In this scenario, those cured patients will never experience the
event of interest, even the follow-up period is sufficient. To account for this curable part,
mixture cure model has been specifically designed to be applied for this type of study [810]. Different from the standard survival model, one advantage of the mixture cure model
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is that it has two separate components to model the cure probability for the cured part and
the survival probability for the uncured patients, respectively. The most popular mixture
cure model for analyzing survival data was proposed by Boag [11], which could estimate
the cure rate of the cured patients and the survival probability of uncured patients in the
meantime.
Let 𝑇 be a nonnegative random variable denoting the observed time of a patient,
which is the minimum of the failure time and censoring time. We assume that 𝑇 is
independent of censoring. Let 𝑆(𝑡|𝒙, 𝒛)denote the survival functions of 𝑇, where 𝒙 and 𝒛
are observed values of two covariate vectors on which the distribution of 𝑇 may depend.
The mixture cure model is then given by

𝑆(𝑡 |𝒙, 𝒛) = 𝜋(𝒛) + (1 − 𝜋(𝒛))𝑆𝑢 (𝑡 |𝒙)

(1.2)

where 𝑆(𝑡|𝒙, 𝒛) denotes the overall survival function. 𝜋(𝒛) is usually referred to as the
“incidence” part, which is the probability of being cured giving predictors 𝒛 via the inverse
logistic function,

𝜋 (𝒛 ) =

exp(𝜸′ 𝒛)

(1.3)

1+exp(𝜸′ 𝒛)

𝑆𝑢 (𝑡|𝒙) is usually referred as “latency” part, which is the survival function of the uncured
subjects depending on 𝒙. Under the proportional hazards model assumption, that is

𝑆𝑢 (𝑡|𝒙) = 𝑆0 (𝑡|𝒙)𝑒

𝜷𝒙

the above model (1.2) and (1.3) become PH mixture cure model.
There’s an existing R package “smcure” developed for analyzing mixture cure
models [12]. The package can estimate semiparametric PH mixture cure model and
semiparametric accelerating failure time (AFT) mixture cure model, based on the EM

4

algorithm. In SAS, there’s an existing macro called PSPMCM which accounts for the
PHMC model and the parametric approach for the AFTMC model [13].

1.4 SAMPLE SIZE CALCULATION FOR PROPORTIONAL HAZARDS MIXTURE CURE
MODEL
For mixture cure models, the most common case is that the covariate is binary
variable, such as only including the control and treatment arm. If let 𝑗 = 0, 1 denote the
control and treatment arm; 𝜋0 , 𝜋1 denote cure rate for control arm and treatment arm;
𝜆0 (𝑡), 𝜆1 (𝑡) denote the hazard function for control arm and treatment arm; 𝛽0 denote the
log-hazard ratio between two arms and 𝛾0 denote the log-odds ratio between two arms.
𝑆𝑗∗ (•) Denotes the overall survival function and 𝑆𝑗 (•) denote the survival function of
uncured patients. The mixture cure model is as follows,
𝑆𝑗∗ (𝑡) = 𝜋𝑗 + (1 −  𝜋𝑗 )𝑆𝑗 (𝑡)
𝜆1 (𝑡) = 𝑒 𝛽0 𝜆0 (𝑡)
which accounts for the constant hazard ratio.
𝑙𝑜𝑔𝑖𝑡(𝜋1 ) = 𝑙𝑜𝑔𝑖𝑡(𝜋0 ) + 𝛾0
which accounts for the constant odds ratio. In a special case that, when 𝜋0 = 𝜋1 = 0, it
reduces to the standard PH model.
For a survival trial with a proportion of patients being cured, the hypothesis of
interest is listed as follows,
𝐻0 ∶  𝛽0 = 𝛾0 = 0

VS

𝐻𝑎 : 𝑎𝑡𝑙𝑒𝑎𝑠𝑡𝑜𝑛𝑒𝑜𝑓(𝛽0 , 𝛾0 ) ≠ 0

The alternative hypothesis 𝐻𝑎 includes the following cases,
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1) 𝛽0 ≠ 0, 𝛾0 ≠ 0: treatment has effects on both cure rate and survival probability
of uncured patients;
2) 𝛽0 ≠ 0, 𝛾0 = 0: treatment only has effect on survival probability of uncured
patients;
3) 𝛽0 = 0, 𝛾0 ≠ 0: treatment only has effect on cure rate.
Wang et al. developed a sample size formula for the PH mixture cure model based
on the log rank test [14]:
For power 1 − 𝜃 and significance level α,
∞

𝑛=

(𝑍𝜃 +𝑍𝛼⁄2 )2 ∫0 𝑆𝐶 (𝑡)𝑓0 (𝑡)𝑑𝑡
∞

2

𝑝(1−𝑝)(1−𝜋0 ){∫0 𝑚(𝛾0 ,𝛽0 ,𝜋0 )𝑆𝐶 (𝑡)𝑓0 (𝑡)𝑑𝑡}

(1.4)

where 𝑚(𝛾0 , 𝛽0 , 𝜋0 ) = 𝜋0 {𝛾0 + 𝛬0 (𝑡)𝛽0 }/𝑆0∗ (𝑡) − 𝛽0
𝑝 is the proportion of subjects in the treatment arm; 𝜋0 is the cure rate for control arm. 𝛽0
denotes the log-hazard ratio between two arms and 𝛾0 denotes the log-odds ratio between
two arms. 𝑆𝐶 (𝑡) is the survival function of censoring time and 𝑓0 (𝑡) is the density function
of survival times for uncured patients in the control arm. 𝑆0∗ (𝑡) is the overall survival
function in the control arm.
When 𝜋0 = 0, there’s no cured part, and (1.4) reduces to the sample size formula
for standard PH model in (1.1).
Therefore, this sample size formula extends the original formula for standard PH
model by allowing a cure fraction. In Wang’s paper [14], effects of the difference in the
short-term survival and the difference in the cure fraction on the sample size has been
studied, which are usually of main interest in many survival trials. Impacts of various
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accrual rate patterns, including uniform, increasing, and decreasing, and also the length of
accrual and follow-up periods on the estimated sample size have been illustrated.
Cai. et al implement the above sample size calculation method in R and develop a
R package NPHMC [15]. In their package, they include many options as discussed in the
paper. First, they provide option for accrual pattern, such as uniform, increasing, and
decreasing; Secondly, the base hazard function for treatment is also flexible, which
includes two parametric distributions, exponential and Weibull; Thirdly, in their output
interface, either the sample size or power can be reported by given either power or sample
size and power curves can be generated for multiple sample sizes for power analysis;
Lastly, the package can either do the parametric estimation based on the known parameters,
or do the nonparametric estimation from the available dataset.

1.5 MOTIVATION AND OUTLINE OF THESIS
Based on Wang’s method, the sample size for the PH mixture cure model can be
conveniently calculated. However, in the original method, the probability of death is
contributed only from the control arm, which may either underestimate or overestimate the
power. It’s expected that when calculating the probability of death, if it can be accounted
for in both arms, sample size calculation will be more precise comparing with the current
method. The outline of the thesis is listed as follows,
In Chapter 2, we introduce the method of modification for sample size calculation
under PH mixture cure model, using both the Schoenfeld [4] and Ewell [16] method.
Secondly, the formula was updated to be adapted to cases with lognormal distribution in
hazard function. Thirdly, formulas are developed to be used for nonbinary cases based on
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Hsieh and Lavori’s method [17], under exponential, Weibull and lognormal distribution in
hazard function. All the methods are illustrated with notation specification, formulas and
implementation in R.
In Chapter 3, extensive simulation are conducted to check the performance of the
proposed methods. We first compare the performance of the three methods under different
distribution in hazard function, by comparing the empirical power with the nominal power.
Secondly, for each method, parametric estimation has been compared with nonparametric
estimation.
In Chapter 4, the proposed method has been applied to the melanoma dataset from
ECOG phase III clinical trial E1684. Furthermore, power analysis has been conducted
using the proposed method, under various settings.
Finally in Chapter 5, we summarize all the work and present some discussion and
conclusions for future work.
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CHAPTER 2 METHODS AND SOFTWARE IMPLEMENTATION
In this chapter, methods used for formula modification and implementation are
illustrated. Section 2.1 introduces the motivation and presents our two proposed
modification methods; section 2.2 extends the current method and the two proposed
method to lognormal distribution; section 2.3 demonstrates the components specification
for how to apply all three methods in sample size calculation, under three distributions
( exponential, Weibull and lognormal); section 2.4 develops the nonparametric estimation
method using the two proposed methods; section 2.5 demonstrate the implementation of
the three methods in R; section 2.5 further extends the methods to the sample size
calculation for nonbinary cases.

2.1 SCHOENFELD AND EWELL METHOD MODIFICATION
For the sample size formula proposed by Wang in (1.4), the probability of death
(𝑃[𝛿 = 1] ) is calculated only from the control arm, which may either underestimate or
overestimate the necessary sample size.
For sample size calculation in standard PH model, Schoenfeld [4] proposed a
method to adjust the calculation of the probability of death, based on both the control and
the treatment arm, with 𝑝 denoting the proportion of subjects in the treatment arm.
𝑃(𝛿 = 1) = 𝑝𝑃(𝛿 = 1|𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡) + (1 − 𝑝)𝑃(𝛿 = 1|𝐶𝑜𝑛𝑡𝑟𝑜𝑙)
We refer to this method as Schoenfeld method. If we expand the formula, it is as follows,
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𝑛=

(𝑍𝜃 + 𝑍𝛼⁄2 )2

∞

∞

𝑝(1 − 𝑝)𝛽02 {𝑝 ∫0 𝑆𝐶 (𝑡)𝑓1 (𝑡) 𝑑𝑡 + (1 − 𝑝) ∫0 𝑆𝐶 (𝑡)𝑓0 (𝑡) 𝑑𝑡}

It is apparent that it accounts for the different density function between the control and
treatment arm, which is closer to the real situation.
̅
Instead of 𝑓0 (𝑡) in Wang’s method, 𝑓 (𝑡)
is applied to formula which is an average
probability density function from both the control arm and treatment arm.
𝑓 (̅ 𝑡) = 𝑝𝑓1 (𝑡) + (1 − 𝑝)𝑓0 (𝑡)
̅ , it becomes the modified sample size
By substituting the 𝑓0 in Wang’s method by 𝑓
calculation formula, which is written as
∞

𝑛=

(𝑍𝜃 +𝑍𝛼⁄2 )2 ∫0 𝑆𝐶 (𝑡)𝑓̅(𝑡)𝑑𝑡

2

∞
̅ (𝛾0 ,𝛽0 ,𝜋0 )𝑆𝐶 (𝑡)𝑓̅(𝑡)𝑑𝑡}
𝑝(1−𝑝)(1−𝜋0 ){∫0 𝑚

(2.1)

where 𝑚
̅ (𝛾0 , 𝛽0 , 𝜋0 ) = 𝜋0 {𝛾0 + 𝛬̅(𝑡)𝛽0 }/𝑆̅ ∗ (𝑡) − 𝛽0.
As for the numeric average of density function, other components can be derived
similarly, which are listed as follows,


𝑓 (̅ 𝑡) = 𝑝𝑓1 (𝑡) + (1 − 𝑝)𝑓0 (𝑡),

𝑆̅(𝑡) = 𝑝𝑆1 (𝑡) + (1 − 𝑝)𝑆0 (𝑡)



𝑆̅ ∗ (𝑡) = 𝜋0 + (1 − 𝜋0 )𝑆0̅ (𝑡),

𝛬̅(𝑡) = −𝑙𝑜𝑔𝑆̅(𝑡)

Besides the Schoenfeld method which averages the density function first, an
alternative method proposed by Ewell [16] which aims to average the hazard function first
and we refer to it as Ewell method. First, the weighted hazard function was calculated from
the square root of the product of hazard function from both control and treatment arms.
Then the density function and survival function is calculated based on the hazard function.
We listed each component as follows:
Ewell method:
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𝛬𝑖 (𝑡): Cumulative hazard function of the 𝑖 𝑡ℎ group, where 𝑖 = 0,1


𝛬̅(𝑡) = 𝛬1 (𝑡)𝑝 𝛬0 (𝑡)1−𝑝 ,

𝑆̅(𝑡) = exp{−𝛬̅(𝑡)}



𝑆̅ ∗ (𝑡) = 𝜋0 + (1 − 𝜋0 )𝑆0̅ (𝑡),

𝑓(̅ 𝑡 ) = −

𝜕𝑆̅(𝑡)
𝜕𝑡

̅ , which is
Similar as Schoenfeld method, 𝑓0 in Wang’s method is substituted by 𝑓
calculated based on Ewell method. Then the other components calculated as above are
substituted into the formula.

2.2 LOGNORMAL DISTRIBUTION
As mentioned before, the existing method and package only cover exponential and
Weibull distribution, in our study all three methods has been accommodated to lognormal
distribution.
Formulas for lognormal distribution in R will be utilized here. Similar as for the
exponential and Weibull distributions, the Wang method calculates the probability of death
based on the control arm, while Schoenfeld method acquires the weighted functions from
the numeric average of both the control and treatment arm. The Ewell method uses the
geometric average to get necessary functions. Some related formulas are as follows,
 Wang method:
𝑆0 (𝑡) = 1 − 𝑝𝑛𝑜𝑟𝑚(
𝑓0 (𝑡) = 𝑑𝑛𝑜𝑟𝑚 (

lnt−µ0
𝜎0

lnt−µ0
𝜎0

),

1 1

) 𝜎 𝑡,
0

𝑆0 ∗ (𝑡) = 𝜋0 + (1 − 𝜋0 )𝑆0 (𝑡),
𝛬0 (𝑡) = −log(𝑆0 (𝑡)).

 Schoenfeld method:
𝑆0 (𝑡) = 1 − 𝑝𝑛𝑜𝑟𝑚(

lnt−µ0
𝜎0

),

𝛽

𝑆1 (𝑡) = 𝑆0 (𝑡)𝑒 ,
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𝑓0 (𝑡) = 𝑑𝑛𝑜𝑟𝑚 (

lnt−µ0
𝜎0

1 1

𝑓1 (𝑥) = 𝑒 𝛽 𝑆0 (𝑡)𝑒

) 𝜎 𝑡,
0

𝛽 −1

𝑓0 (𝑡)

 Ewell method:
𝑆0 (𝑡) = 1 − 𝑝𝑛𝑜𝑟𝑚(

lnt−µ0
𝜎0

),

𝛽

𝑆1 (𝑡) = 𝑆0 (𝑡)𝑒 ,

𝛬0 (𝑡) = −log(𝑆0 (𝑡)),

𝛬1 (𝑡) = −log(𝑆1(𝑡)),

𝛬̅(𝑡) =  𝛬1 (𝑡)𝑝 𝛬0 (𝑡)1−𝑝 ,

𝑆̅(𝑡) = exp(−𝛬̅(𝑡)),

𝑆̅ ∗ (𝑡) = 𝜋0 + (1 − 𝜋0 )𝑆̅(𝑡),

𝑓 (̅ 𝑡) = exp(−𝛬̅(𝑡))

̅ (𝑡)
𝜕𝛬
𝜕𝑡

.

2.3 COMPONENT SPECIFICATIONS
To calculate the sample size using the formula shown above, several components
need to be specified, such as survival function of censoring time, corresponding to different
accrual patterns. There are three patterns considered here, uniform, increasing and
decreasing. Specifically, if we let 𝜏𝑎 and 𝜏𝑓 denote the accrual and the follow-up period,
respectively; 𝑔(𝑡) denote the probability density function of accrual times. Their
corresponding survival function of the censoring times are summarized in the table below,
which will be substituted into the formula.
For the density function of survival probability, we’ll consider three different
parametric distributions, including exponential, Weibull and lognormal. The lognormal
distribution is the new feature we add to the original package. Some expressions for the
three distributions are as follows:
Exponential Distribution
𝜆0 (𝑡) = 𝜆0 𝑘,

𝛬0 (𝑡) = 𝜆0 𝑡,

𝑓0 (𝑡) = 𝜆0 exp(−𝜆0 𝑡) ,𝑓𝑜𝑟𝑡 > 0.
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𝑆0 (𝑡) = 𝑒 −𝜆0 𝑡 ,

Table 2.1 Density Functions g(t) of Accrual Times and Survival Functions 𝑆𝑐 (𝑡) of
Censoring Times

Weibull Distribution
𝜆0 (𝑡) = 𝜆0 𝑘(𝜆0 𝑡)𝑘−1 ,

𝑘

𝛬0 (𝑡) = (𝜆0 𝑡)𝑘 ,

𝑆0 (𝑡) = 𝑒 −(𝜆0 𝑡) ,

𝑓0 (𝑡) = 𝜆0 𝑘(𝜆0 𝑡)𝑘−1 exp(−(𝜆0 𝑡)𝑘 ) ,𝑓𝑜𝑟𝑡 > 0.
Lognormal Distribution
𝑆0 (𝑡) = 1 − 𝑝𝑛𝑜𝑟𝑚(

𝑙𝑛𝑡−µ0
𝜎0

𝑓0 (𝑡) = 𝑑𝑛𝑜𝑟𝑚 (

),

𝑙𝑛𝑡−µ0
𝜎0

1 1

)𝜎

0

𝑡

̅
To apply the Schoenfeld or Ewell method is to calculate 𝑓(𝑡),
𝑆̅(𝑡), 𝑆̅ ∗ (𝑡) and 𝛬̅(𝑡)
based on the above equations, discussed in section 2.2, respectively. Then those calculated
average functions are substituted into the formula (2.1). For example, if a trial has uniform
distribution for the accrual period, for power 1 − 𝜃 and significance level α, the sample
size can be calculated as the following,
2

𝑛=

𝜏𝑎 +𝜏𝑓 𝜏𝑎 +𝜏𝑓 −𝑡

𝑓̅(𝑡)𝑑𝑡}
𝜏𝑎

𝜏𝑓

(𝑧𝜃 +𝑧𝛼⁄2 ) {∫0 𝑓̅(𝑡)𝑑𝑡+∫𝜏
𝑓

𝜏 +𝜏𝑓 𝜏𝑎 +𝜏𝑓 −𝑡

𝜏

𝑎
𝑓
̅ (𝛾0 ,𝛽0 ,𝜋0 )𝑓̅(𝑡)𝑑𝑡+∫𝜏
𝑝(1−𝑝)(1−𝜋0 ){∫0 𝑚
𝑓

where 𝑚
̅ (𝛾0 , 𝛽0 , 𝜋0 ) = 𝜋0 {𝛾0 + 𝛬̅(𝑡)𝛽0 }/𝑆̅ ∗ (𝑡) − 𝛽0.
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𝜏𝑎

2

̅ (𝛾0 ,𝛽0 ,𝜋0 )𝑓̅(𝑡)𝑑𝑡}
𝑚

2.4 EXAMPLES FOR NONPARAMETRIC ASSUMPTION
Alternative to parametric assumptions, the sample size for nonparametric
assumptions could also be calculated. If a dataset is available, the baseline survival function,
cure rate and hazard ratio could be first estimated by an existing R package, smcure, which
is developed for mixture cure model. By specifying the significance level, power and
accrual pattern, the sample size can be attained as follows,

𝑛=

2
(𝑧𝜃 + 𝑧𝛼⁄2 ) ∑𝑘𝑖=1 𝑆̂0 (𝑡(𝑖) ) 𝑆𝑐 (𝑡(𝑖) )
2
𝑝(1 − 𝑝)(1 − 𝜋0 ){∑𝑘𝑖=1 𝑆̂0 (𝑡(𝑖) ) 𝑆𝑐 (𝑡(𝑖) )𝑚
̂ (𝛾̂0 , 𝛽̂0 , 𝜋̂0 ; 𝑡(𝑖) )}

where 𝑚
̂ (𝛾̂0 , 𝛽̂0 , 𝜋̂0 ; 𝑡(𝑖) ) = 𝜋̂0 {𝛾̂0 + 𝛬̂(𝑡)𝛽̂0 }/𝑆̂ ∗ (𝑡) − 𝛽̂0
𝛬̂0 (𝑡) = −𝑙𝑜𝑔𝑆̂0 (𝑡),

∗
𝑆̂0 (𝑡) = 𝜋̂0 + (1 − 𝜋̂0 )𝑆̂0 (𝑡)

Similar to the parametric one, numeric or geometric average will be calculated for
Schoenfeld and Ewell method as following,

Schoenfeld method:
𝑆̂0 (𝑡): estimated from smcure package,
̂

𝛽
𝑆̂1 (𝑡) = 𝑆̂0 (𝑡)𝑒 0 ,

𝑆̂(𝑡) = 𝑝𝑆̂1 (𝑡) + (1 − 𝑝)𝑆̂0 (𝑡),

∗
𝑆̂0 (𝑡) = 𝜋̂0 + (1 − 𝜋̂0 )𝑆̂0 (𝑡),𝛬̂(𝑡) = −log(𝑆̂(𝑡)).

Ewell method:
𝑆̂0 (𝑡): estimated from smcure package,
̂

𝛽
𝑆̂1 (𝑡) = 𝑆̂0 (𝑡)𝑒 0 ,

𝛬̂0 (𝑡) = −log(𝑆̂0 (𝑡)),

̂
𝛬̂1 (𝑡) = − log (𝑆̂1 (𝑡)) = −𝑒 𝛽0 log(𝑆̂0 (𝑡)),

𝑆̂(𝑡) = exp(−𝛬̂(𝑡)),

𝛬̂(𝑡) = 𝛬̂1 (𝑡)𝑝 𝛬̂0 (𝑡)1−𝑝 ,

𝑆̂ ∗ (𝑡) = 𝜋̂0 + (1 − 𝜋̂0 )𝑆̂(𝑡)
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2.5 IMPLEMENTATION IN R
The sample size formula under the exponential, Weibull and lognormal distribution
and also for the nonparametric estimation with different accrual patterns are implemented
in “allNPHMC” package we developed. The function can be called using the following
syntax:
allNPHMC <- function (n, power, alpha, accrualtime, followuptime, p, accrualdist=
c(“uniform”, ”increasing”, “decreasing”), hazardratio, oddsratio, pi0, survdist =
c(“exp”,”weib”,”lgnorm”), shape, scale, data=NULL, output=NULL)
The arguments are as follows:


n: the sample size needed for the power calculation.



power: the power needed for sample size calculation, default is 90%.



alpha: the level of significance of the statistical test, default is 0.05.



accrualtime: the length of accrual period.



followuptime: the length of follow-up time.



p: the proportion of subjects in the treatment arm, default is 0.5.



accrualdist: the accrual pattern. It can be "uniform","increasing" or "decreasing".



hazardratio: the hazard ratio of uncured patients between two arms, which is defined
as 𝑒 𝛽0 = 𝜆1 (𝑡)⁄𝜆0 (𝑡). The value must be greater than 0 and not equal to 1.



oddsratio: the odds ratio of cure rates between two arms, which is equivalent to 𝑒 𝛾0 =
[𝜋1 ⁄(1 − 𝜋1 )]⁄[𝜋0 ⁄(1 − 𝜋0 )] . The value should be greater than 0 if there’s cured
fraction. When it is 0, the model is reduced to the standard proportional hazards model,
which means there is no cure rate.



pi0: the cure rate for the control arm, which is between 0 and 1.



survdist: the survival distribution of uncured patients. It can be “exp”, “weib” or
“lgnorm”.



shape: shape parameter for distribution of survival function. By default shape=1, which
refers to the exponential distribution.
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scale: scale parameter for distribution of survival function.



data: if observed/historical data is available, the sample size can be calculated based
on the nonparametric estimators from the PH mixture cure model by smcure package
in R. The data must contain three columns with the order of “Time”, “Status” and “X”
where “Time” refers to observed time, “Status” refers to censoring indicator (1 = event
of interest happens, and 0 = censoring) and “X” refers to arm indicator (1 = treatment
and 0 = control). By default, data = NULL.



method: It can be “wang”,”schoenfeld”,”ewell”. if output is NULL, only result from
Schoenfeld method will be output. To obtain the results from all three method (Wang,
Schoenfeld, Ewell), method should be set to “all”. By default, output = NULL.

Remarks:
“oddsratio = 1” can be specified if we believe the difference between two arms
does not exist in the cure fraction. “hazardratio = 1” (𝛽0 = 0) can also be specified if we
believe the difference between two arms does not exist in the uncured fraction. If the
argument “data” is not “NULL”, the “hazardratio” and the “oddsratio” will be
automatically calculated based on the output from smcure package. If the argument “data”
is not “NULL” and the “hazardratio” and the “oddsratio” are given, it will give a warning
message as “The “hazardratio” and the “oddsratio” are not needed when the data option
is specified. If the argument “data” is “NULL”, the value of the “hazardratio” and the
“oddsratio” need to be specified.
If power (sample size) and significant level of statistical test is given, the output of sample
size (power) calculation is as follows:
If data = NULL, the output will display:


PH Mixture Cure Model: n (Power)
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Standard PH Model: n (Power)

If data is specified: the output will display:


Estimators from smcure package



PH Mixture Cure Model: n (Power)



Standard PH Model: n (Power)

2.6 SAMPLE SIZE CALCULATION FOR NONBINARY COVARIATE
In many experiments, the covariates are not binary variables, such as the covariates
recording the dose levels, or the covariates being as risk factors, such as numbers of
cigarettes smoked per day. To apply our sample size calculation method to this type of
study, the above formula has been modified to accommodate to the nonbinary covariates.
In 2000, Hsieh et al. proposed a sample size formula for nonbinary covariate without
assuming any distribution on survival time. As seen from the above formula for standard
PH model, the variance from the binary covariate contributes as 𝑝(1 − 𝑝). When applied
to the nonbinary covariate, this variance item should be replaced by the variance of the
nonbinary covariate, which is typically denoted as 𝜎 2 .
Thus, the sample size for standard PH model is calculated as the following,

(𝑍𝜃 + 𝑍𝛼⁄2 )2
𝑛= 2 2
𝜎 𝛽0 𝑃(𝛿 = 1)
Based on above Hsieh’s method, sample size for mixture cure model with nonbinary
covariate could be calculated as follows,
 Wang method:
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∞

𝑛=

(𝑍𝜃 +𝑍𝛼⁄2 )2 ∫0 𝑆𝐶 (𝑡)𝑓0 (𝑡)𝑑𝑡
∞

2

𝜎02 (1−𝜋0 ){∫0 𝑚(𝛾0 ,𝛽0 ,𝜋0 )𝑆𝐶 (𝑡)𝑓0 (𝑡)𝑑𝑡}

 Ewell method:

(15)

(16)

Exponential and Weibull distribution:
𝛬̅(𝑡) = 𝛬0 (𝑡)𝑒 𝛽𝑥̅ ,

𝛬0 (𝑡) = (𝜆0 𝑡)𝑘 ,
𝑓 (̅ 𝑡) = −

𝑆̅(𝑡) = exp(−(𝜆0 𝑡)𝑘 𝑒 𝛽𝑥̅ )

𝜕𝑆̅(𝑡)
= 𝑆̅(𝑡)𝑒 𝛽𝑥̅ 𝑘(𝜆0 𝑡)𝑘−1 𝜆0
𝜕𝑡

Lognormal distribution:
𝑙𝑛𝑡−µ0

𝑆0 (𝑡) = 1 − 𝑝𝑛𝑜𝑟𝑚 (
𝛬̅(𝑡) = 𝛬0 (𝑡)𝑒 𝛽𝑥̅ ,
𝑓 (̅ 𝑡) = −

𝜎0

𝛬0 (𝑡) = − log(𝑆0 (𝑡)),

),

𝑆̅(𝑡) = exp[−𝛬̅(𝑡)] = exp[−𝛬0 (𝑡)𝑒 𝛽𝑥̅ ]

𝜕𝑆̅(𝑡)
1
𝑙𝑛𝑡 − µ0 1 1
= exp[−𝛬̅(𝑡)]𝑒 𝛽𝑥̅
𝑑𝑛𝑜𝑟𝑚(
)
𝜕𝑡
𝑆0 (𝑡)
𝜎0
𝑡 𝜆0

Here the interpretation for the hazard ratio and odds ratio has changed. Compared
to the binary case, both the hazard ratio and the odds ratio are now interpreted as change
of the hazard function being associated with one unit change in corresponding covariate.
Comment: we only use the Ewell method, because its expression can be expanded
to the continuous variable conveniently. For Schoenfeld method, to calculate the mean of
the continuous case, it will involve the integration without the closed form. The numerical
integration may be needed and thus currently we choose the easily implementable approach.
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CHAPTER 3 SIMULATION STUDY
The purpose of this chapter is to conduct comprehensive simulation studies to
investigate the performance of the proposed sample size calculations.
In section 3.1, we first evaluate the consistency of the nominal power and empirical
power based on all three different methods (Wang, Schoenfeld and Ewell methods) under
different simulation settings. The empirical power attained based on 2000 simulations will
be compared to the nominal power which is set at 0.9 here. Performance will be evaluated
based on the relative difference between the empirical power and the nominal power.
In section 3.2, performance of three methods will be evaluated by checking the
consistency between parametric estimation and nonparametric estimation for each method.
For each set of parameters, we compare the sample size from the fully specified distribution
with from the fully nonparametric approach.
Lastly, in section 3.3, we extend the simulation to the continuous variable based on
the formula provided in section 2.6. Wang and Ewell method has been applied. Simulation
has been conducted to compare the performance of these two methods, under different
distributions of hazard function, including exponential, Weibull and lognormal.
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3.1 SIMULATION COMPARING WANG, SCHOENFELD AND EWELL METHODS
3.1.1 SIMULATION SETTINGS
EXPONENTIAL DISTRIBUTION
The following settings are used in the simulation study for exponential distribution.
Covariate data are generated from a binomial distribution, which corresponding to control
arm and treatment arm, with equal allocation.
We specifically consider the control and treatment arm follow the mixture cure
model with the exponential distribution, which can be written as
𝑆0 (𝑡) = 𝜋0 + (1 − 𝜋0 )𝑒 −𝜆0𝑡
𝑆1 (𝑡) = 𝜋1 + (1 − 𝜋1 )𝑒 −𝜆1 𝑡
𝜋

𝜋

Which leads to the odds ratio as log(1−𝜋0 ⁄1−𝜋1 ) and hazard ratio as
0

1

𝜆1
𝜆0

.

1) The scale parameter is set at 𝜆0 = 0.1, 0.20.3., which correspondes to the mean
survival time of control group as 10, 5, 2.
2) For each 𝜆0 , cure rate for control arm 𝜋0 is set at 0.4 and 0.3.
The choice of 𝜆1 𝑎𝑛𝑑𝜋1 are determined by the odds ratio and hazard ratio, which is set up
as: 𝑒 −𝛽0 is at (1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8), 𝑒 𝛾0 is at (0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0),
which correspond to 𝜋1 = (0.211, 0.25, 0.286, 0.318, 0.348, 0.375, 0.4) for 𝜋0 = 0.4
and 𝜋1 = (0.146, 0.176, 0.205, 0.231, 0.255, 0.278, 0.3) for 𝜋0 = 0.3. For 𝜆0 = 0.1, 𝜆1
is varied at (0.083, 0.077, 0.071, 0.067, 0.063, 0.059, 0.056); For 𝜆0 = 0.2, 𝜆1 is varied at
(0.167, 0.154, 0.143, 0.133, 0.125, 0.118, 0.111); For 𝜆0 = 0.5, 𝜆1 is varied at (0.417,
0.385, 0.357, 0.333, 0.313, 0.294, 0.278). And thus the mean survival time of treatment
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arm is varied at (12, 13, 14, 15, 16, 17, 18), (6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0), (2.4, 2.6, 2.8,
3.0, 3.2, 3.4, 3.6).
To calculate the empirical power, the sample size at power 90% should be specified.
The formula to calculate the sample size is reduced to
𝑛=

42.03
= 1)

𝛽02 𝑃(𝛿

The censoring distribution is calculated based on section 2.3. For example,
assuming uniform distribution in the accrual period with an accrual period of 1 year and a
follow up time of 4 years; For 𝜋0 = 0.4,the mean censoring rate is 0.83, 0.72, 0.56 for
𝜆0 = 0.1, 0.2, 0.5, respectively. For 𝜋0 = 0.3, the mean censoring rate is 0.80, 0.67 and
0.48.
Weibull distribution
Settings used in the simulation study for Weibull distribution are listed as follows:
Control and treatment group follow the mixture cure model with the Weibull distribution,
which can be written as
𝑆0 (𝑡) = 𝜋0 + (1 − 𝜋0 )𝑒 −(𝜆0 𝑡)

𝑘

𝑘

𝑆1 (𝑡) = 𝜋1 + (1 − 𝜋1 )𝑒 −(𝜆1 𝑡)
𝜋

𝜆

𝜋

Which leads to the odds ratio as log (1−𝜋0 ⁄1−𝜋1 ) and hazard ratio as (𝜆1)𝑘 .
0

1

0

1) The shape parameter 𝑘 is set at 2. Scale parameter is set at 𝜆0 = 0.1, 0.20.3., which
corresponding to the mean survival time of control group as 8.862, 4.431, 2.954.
2) For each 𝜆0 , cure rate for control arm 𝜋0 is set at 0.4 and 0.3.
The choice of 𝜆1 𝑎𝑛𝑑𝜋1 are determined by the odds ratio and hazard ratio, which
are set up as: 𝑒 −𝛽0 is at (1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8), 𝑒 𝛾0 is at (0.4, 0.5, 0.6, 0.7, 0.8,
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0.9, 1.0), which corresponding to 𝜋1 = (0.211, 0.25, 0.286, 0.318, 0.348, 0.375, 0.4) for
𝜋0 = 0.4 and 𝜋1 = (0.146, 0.176, 0.205, 0.231, 0.255, 0.278, 0.3) for 𝜋0 = 0.3 . For
𝜆0 = 0.1, 𝜆1 is varied at (0.091, 0.088, 0.085, 0.082, 0.079, 0.077, 0.075); For 𝜆0 = 0.2,
𝜆1 is varied at (0.183, 0.175, 0.169, 0.163, 0.158, 0.153, 0.149); For 𝜆0 = 0.3, 𝜆1 is varied
at (0.274, 0.263, 0.254, 0.245, 0.237, 0.230, 0.224). And thus the mean survival time of
treatment group is varied at (9.708, 10.105, 10.486, 10.854, 11.210, 11.555, 11.890), (4.854,
5.052, 5.243, 5.427, 5.605, 5.777, 5.945), (3.236, 3.368, 3.495, 3.618, 3.737, 3.852, 3.963).
For 𝜋0 = 0.4, the mean censoring rate is 0.92, 0.74, 0.59 for 𝜆0 = 0.1, 0.2, 0.3 ,
respectively. For 𝜋0 = 0.3, the mean censoring rate is 0.90, 0.69 and 0.52.
Lognormal distribution
Besides Exponential and Weibull distribution, simulation is also conducted on
lognormal distribution. The specific settings are listed below:
Control and treatment arm follow the mixture cure model with the lognormal distribution,
which can be written as
𝑙𝑛𝑡 − µ0
𝑆0 (𝑡) = 𝜋0 + (1 − 𝜋0 )(1 − 𝑝𝑛𝑜𝑟𝑚 (
))
𝜎0
𝑆1 (𝑡) = 𝜋1 + (1 − 𝜋1 )𝑆0 (𝑡)𝑒
𝜋

𝛽0

𝜋

Which leads to the odds ratio as log (1−𝜋0 ⁄1−𝜋1 ) .
0

1

1) Scale parameter is set at 𝜎0 = 1.5, 2.5, 3.5., which corresponding to the mean
survival time of control group as 8.373, 61.868, 1242.648.
2) For each 𝜎0 , cure rate for control arm 𝜋0 is set at 0.4 and 0.3.
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3) The setting of hazard ratio between two groups is the same as exponential and
Weibull distribution. The setting of cure rates for control group and treatment group
is the same as exponential and Weibull distribution.
4) The censoring distribution is calculated based on section 2.3. For example,
assuming uniform distribution in the accrual period with an accrual period of 1 year
and a follow up time of 15 years; For 𝜋0 = 0.4,the mean censoring rate is 0.57,
0.64, 0.68 for 𝜎0 = 1.5, 2.5, 3.5, respectively. For 𝜋0 = 0.3, the mean censoring
rate is 0.49, 0.57 and 0.61.

3.1.2 SIMULATION RESULTS
For each set of data, censoring rate, estimated sample size, empirical power is
reported. To evaluate the performance of all three methods, the absolute relative bias is
reported, which is calculated as
|empiricalpower−0.9|
0.9

× 100%,

The absolute relative bias can measure the distance of the estimated power to the nominal
power. A smaller relative bias indicates that the empirical value is closer to the nominal
value, which is set at 0.9 here. For comparison purposes, the absolute relative biases from
all methods are illustrated in Figure 3.1-3.6. In all the plots, the y-axis denotes the absolute
relative bias, and x-axis denotes the hazard ratio. Three different methods are denoted by
dotted lines, where Wang method is denoted as “Wang” in blue dotted line, Schoenfeld
method is denoted as “Schoenfeld” in yellow dotted line and Ewell method is denoted as
“Ewell” in red dotted line. The other specific settings are denoted by the label in each figure,
which include the scale and shape parameters, accrual and follow up time, cure rate and
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mean censoring rate. The three plots in the left panel is all for 𝜋0 = 0.4, while the other
three plots in the right panel is for 𝜋0 = 0.3.
Figure 3.1 compares the three methods under exponential distribution. As for the
three graphs in the left panel, with the same cure rate 0.4, censoring rate decreases from
0.83 to 0.56. With the decreasing censoring rate, the absolute relative bias (ARS) from
Wang method experienced the large decrease. This trend can’t be observed for the other
two methods. Comparing all three methods, in relatively high censoring rate (censr = 0.83,
left upper panel), the empirical power calculated by Wang’s method largely under estimate
the power. Compared with the Wang method, Schoenfeld and Ewell methods both work
well, in which the largest deviation from the nominal power 0.9 is only 2%. There’re not
significantly differences between Schoenfeld and Ewell methods. When 𝜆0 = 0.2, censr =
072 ( left, middle panel), Wang method has better performance than in the higher censoring
rate. While for the other two methods, they both maintain good performance in all the
estimation, deviation from the nominal power 0.9 are all smaller than 3%. In the scenario
of even lower censoring rate (censr = 0.56, left low panel). There are not significant
differences among all these three methods, deviation from the nominal power 0.9 are all
smaller than 4%. Similar trends could be observed from the other three graphs in the right
panel, in which 𝜋0 = 0.3. From Figure 3.1, we conclude that both Schoenfeld and Ewell
methods have improvements over the Wang method in the scenarios of high and medium
censoring rates, in which they get more accurate sample size estimation. While for the low
censoring rate case, all these three methods have comparable performance.
If there’s longer follow up period, more events could be detected, which will
certainly lower the censoring rate. Figure 3.2 investigates the performance of the three
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methods under various following up period. The settings are as follows, 𝜋0 = 0.4, 𝜆0 =
0.1, 𝜏𝑎 = 1. 𝜏𝑓 is varied at (4, 10, 15, 20). The same sets of 𝛽0/𝛾0 are used as above. By

Figure 3.1 Simulation for Exponential distribution under parametric condition
adjusting 𝜏𝑓 , mean censoring rates vary from 0.5 to 0.8. The similar conclusion is achieved
as in Figure 3.1. Scho and Ewell methods could get better sample size estimation than
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Wang method in the case of high censoring rate; while at low censoring rate, it couldn’t be
distinguished for the performance among these three methods. The differences between the
empirical power and the nominal power are all less than 4%.

Figure 3.2 Simulation for Exponential distribution, adjusting follow up period

In Weibull distribution, increasing 𝜆0 results in shorter mean survival time and
more event could be detected, and thus lower censoring rate could be acquired. The layout
of Figure 3.3 is similar as Figure 3.1. As is shown here, both Schoenfeld and Ewell methods
show superior performance over Wang method in all scenarios. Most of the results form
Schoenfeld and Ewelll methods show less than 2% deviation from the nominal power 0.9,
while the results from Wang method show as high as 10% deviation from 0.9. The
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differences between Wang and the other two methods are larger in case of higher censoring
rate than in the lower censoring rate.

Figure 3.3 Simulation for Weibull distribution
𝜏𝑓 is also changed for simulation in Weibull distribution. Similar to in the
exponential distribution, by increasing 𝜏𝑓 , more events could be detected, and thus lower
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censoring rate could be achieved. By adjusting 𝜏𝑓 in the range of 𝜏𝑓 = 4, 10, 15, 20, actual
mean censoring rate is achieved at 0.9 ~ 0.5. As shown from the result in Figure 3.4,
Schoenfeld and Ewell method performs significantly better than Wang method when 𝜏𝑓 is
4 and 10, corresponding to the mean censoring rate 0.92 and 0.69. While when mean
censoring rate falls below 0.56, it can’t be distinguished clearly among all three methods.
All of the methods are considered to perform well, as shown from that the empirical powers
are all very close to the nominal power 0.9, and the differences are all less than 4%.

Figure 3.4 Simulation for Weibull distribution, adjusting follow up period
2
In lognormal distribution, mean survival time is calculated as 𝑒 µ+(𝜎0 ) ⁄2 . So in

contrast to the Exponential and Weibull distribution, increasing scale parameter will result
in increasing mean survival time. While keeping all other parameters constant, increasing
mean survival time will introduce higher censoring rate. The scale parameter is varied at
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Figure 3.5 Simulation for Lognormal distribution
𝑠𝑐𝑎𝑙𝑒 = 1.5, 2.5, 3.5, and the mean censoring rate is achieved at 0.48 ~ 0. 67. Comparing
with the other two distributions, the results of the empirical powers for lognormal
distribution is much less sensitive with varying scale parameter.
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Figure 3.5 shows the result for lognormal distribution. For the settings used here,
Schoenfeld and Ewell methods both have much better estimation capability than the Wang
method in all scenarios. And we can’t distinguish between the Schoenfeld and Ewell
methods. Their estimations are very close.

Figure 3.6 Simulation for Lognormal distribution, adjusting follow up period

When adjusting 𝜏𝑓 to compare the estimation performance for all three methods for
lognormal distribution, similar trend is attained as Exponential and Weibull distribution.
As shown in Figure 3.6, estimated empirical power from Schoenfeld and Ewell methods
are much more accurate than that from Wang method, which is shown as much closer to
nominal power 0.9.
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3.2 COMPARISON

OF

PARAMETRIC SAMPLE SIZE ESTIMATION

WITH

NONPARAMETRIC SAMPLE SIZE ESTIMATION

3.2.1 SIMULATION SETTINGS
The model description for each setting are similar as in 3.1. The following settings
are used in the simulation study for exponential and Weibull distribution:
1) scale parameters 𝜆0 = (0.2, 0.3, 0.4, 0.5) and shape parameter 𝑘 = 2 for Weibull
distribution;
2) an accrual period of 3 years and a follow-up time of 4 years;
3) an equal allocation between treatment and control group, 𝑝 = 0.5;
4) a number of 500 observations is generated in each dataset and simulation are based
on 200 replication.
The settings used in the simulation study for lognormal distribution are listed as
follows,
1) scale parameter 𝜎0 = (2, 3, 4), shape parameter µ = 1;
2) an accrual period of 1 year and a follow up period of 15 years;
3) an equal allocation between treatment and control group, 𝑝 = 0.5;
4) a number of 500 observations is generated for each dataset and simulation results
are based on 200 replications.

3.2.2 SIMULATION RESULTS
As shown in Table 3.1, for all three methods, parametric sample size,
nonparametric sample size and 95% CI are reported for each set of parameters. For all the
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three methods, the results from the nonparametric sample size estimation are very close to
the results from the parametric approach, indicating that the estimation method are valid.
Similar to the exponential distribution, in Weibull and lognormal distribution, for
all three methods, the results from the nonparametric sample size estimation are very close
to that from the parametric approach, as shown in Table 3.2 and Table 3.3.

3.3 SIMULATION COMPARING WANG AND EWELL METHODS, FOR NONBINARY
COVARIATE
3.3.1 SIMULATION SETTINGS
The following settings are used in the simulation study for Exponential distribution.
Covariate data are generated from a normal distribution, with mean µ = 0.5and variance
𝜎 2 = 1.
We specifically consider the population follows the mixture cure model with the
Exponential distribution, which can be written as
𝑆0 (𝑡) = 𝜋0 + (1 − 𝜋0 )𝑒 −𝜆0𝑡
𝑆̅(𝑡) = exp(−𝜆0 𝑡𝑒 𝛽𝑥̅ )
1) an accrual period of 1 year and a follow up time of 4 years;
2) Baseline scale parameter is set at 𝜆0 = 0.1, 0.25, 0.75., which corresponding to the
mean survival time of baseline as 10, 4, 1.33.
3) For each 𝜆0 , cure rate for baseline 𝜋0 is set at 0.2 and 0.1.
4) 𝑒 −𝛽0 is at (1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8), 𝑒 𝛾0 is at (0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0).
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Table 3.1 Comparison of Exponential parametric sample size estimation with nonparametric estimation
𝜋0

OR

𝜆0

HR
para
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censoring rate: 0.66 ~ 0.75
0.4 2.226 0.2 0.63 200
2.46
0.2 0.59 158
2.718 0.2 0.56 128
2.226 0.3 0.63 171
2.46
0.3 0.59 135
2.718 0.3 0.56 109
censoring rate: 0.45 ~ 0.64
0.4 2.226 0.4 0.63 162
2.46
0.4 0.59 128
2.718 0.4 0.56 104
0.1 2.46
0.3 0.59 164
2.718 0.3 0.56 133
2.718 0.2 0.56 164
censoring rate: 0.30 ~ 0.38
0.1 2.226 0.4 0.63 189
2.46
0.4 0.59 149
2.718 0.4 0.56 121
2.226 0.5 0.63 183
2.46
0.5 0.59 144
2.718 0.5 0.56 117

Wang
nonpara
95% CI

para

Schoenfeld
nonpara
95% CI

para

Ewell
nonpara
95% CI

247
179
142
209
152
128

( 83 , 581 )
(81, 408)
(68, 303)
( 89 , 563 )
( 63 , 318 )
( 62 , 276 )

228
183
151
185
148
122

241
176
140
203
150
127

( 84 , 554 )
(79, 406)
(68, 306)
( 88 , 504 )
( 65 , 307 )
( 63 , 271 )

229
184
152
185
148
122

241
176
140
204
150
127

( 84 , 553 )
(79, 406)
(69, 306)
( 88 , 502 )
( 65 , 307 )
( 63 , 270 )

190
144
116
208
177
209

( 84 , 367 )
( 76 , 250 )
( 64 , 208 )
( 104 , 391 )
( 92 , 358 )
( 93 , 445 )

169
134
110
186
154
197

187
142
115
206
176
206

( 84 , 354 )
( 76 , 249 )
( 62 , 202 )
( 103 , 381 )
( 92 , 355 )
( 93 , 424 )

168
134
110
186
154
199

187
143
115
206
176
206

( 84 , 354 )
( 76 , 249 )
( 63 , 203 )
( 104 , 383 )
( 93 , 354 )
( 93 , 422 )

255
202
164
238
194
159

( 139 , 553 )
( 100 , 379 )
( 98 , 285 )
( 128 , 485 )
( 95 , 367 )
( 89 , 283 )

205
163
134
191
151
124

252
201
164
237
192
159

( 142 , 540 )
( 102 , 377 )
( 97 , 285 )
( 122 , 483 )
( 95 , 369 )
( 90 , 287 )

204
162
134
190
150
123

252
201
164
237
192
159

( 142 , 540 )
( 101 , 379 )
( 97 , 285 )
( 122 , 483 )
( 95 , 369 )
( 90 , 287 )

Table 3.2 Comparison of Weibull parametric sample size estimation with nonparametric estimation
𝜋0

OR

𝜆0

HR
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para
censoring rate: 0.61 ~ 0.77
0.4 0.8 0.2 1.6 213
0.9 0.2 1.7 167
1
0.2 1.8 136
0.8 0.3 1.6 163
0.9 0.3 1.7 128
1
0.3 1.8 104
censoring rate: 0.37 ~ 0.56
0.4 0.9 0.5 1.7 148
1
0.5 1.8 120
0.9 0.4 1.7 136
1
0.4 1.8 110
0.1 0.9 0.3 1.7 149
1
0.3 1.8 121
censoring rate: 0.17 ~ 0.25
0.1 0.8 0.4 1.6 187
0.9 0.4 1.7 147
1
0.4 1.8 120
0.8 0.5 1.6 203
0.9 0.5 1.7 160
1
0.5 1.8 130

Wang para

Schoenfeld

Ewell

nonpara

95% CI

para

nonpara

95% CI

para

nonpara

95% CI

263
196
160
195
154
124

(102, 606)
( 79 , 479 )
( 72 , 396 )
( 89 , 486 )
( 75 , 305 )
( 62 , 221 )

243
195
161
169
134
110

259
190
155
192
152
122

(99, 593 )
( 77 , 460 )
( 73 , 400 )
( 88 , 465 )
( 74 , 293 )
( 60 , 215 )

245
197
163
169
134
110

259
189
155
193
152
122

(99, 592)
( 78 , 452 )
( 73 , 400 )
( 89 , 468 )
( 74 , 292 )
( 61 , 215 )

165
126
150
120
205
179

( 82 , 322 )
( 70 , 226 )
( 86 , 276 )
( 69 , 211 )
( 109 , 394 )
( 92 , 400 )

138
111
129
104
163
134

156
119
146
115
206
181

( 78 , 289 )
( 66 , 205 )
( 84 , 268 )
( 69 , 197 )
( 110 , 396 )
( 94 , 397 )

141
114
130
105
162
133

159
121
147
116
206
181

( 81 , 299 )
( 66 , 215 )
( 84 , 272 )
( 69 , 199 )
( 110 , 396 )
( 93 , 397 )

231
187
149
237
184
151

( 117 , 463 )
( 103 , 364 )
( 82 , 259 )
( 116 , 497 )
( 102 , 385 )
( 85 , 287 )

183
144
117
191
149
121

228
184
147
226
176
144

( 116 , 465 )
( 99 , 365 )
( 79 , 248 )
( 109 , 480 )
( 95 , 369 )
( 78 , 276 )

183
144
117
194
152
123

228
184
148
229
179
146

( 116 , 466 )
( 99 , 367 )
( 80 , 248 )
( 111 , 484 )
( 97 , 373 )
( 81 , 279 )

Table 3.3 Comparison of Lognormal parametric sample size estimation with nonparametric sample size estimation
𝜋0

OR

𝜎0

HR
para

Wang
nonpara
95% CI
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censoring rate: 0.49 ~ 0.59
0.3 2.014 2 0.67 182
2.226
2 0.63 137
2.46
2 0.59 108
2.226
3 0.63 159
2.46
3 0.59 125
2.226
2 0.56 88

251
196
144
196
158
122

0.3 2.718
2.226
2.46
2.718
0.4 2.46
2.718

3
4
4
4
2
2

0.56
0.63
0.59
0.56
0.59
0.56

102
174
137
112
104
85

129
194
155
126
142
115

0.4 2.226
2.46
2.718
2.226
2.46
2.718

3
3
3
4
4
4

0.63
0.59
0.56
0.63
0.59
0.56

154
121
99
170
134
109

188
145
114
202
167
114

para

Schoenfeld
nonpara
95% CI

( 126 , 641 ) 208
248
( 91 , 435 )
160
194
( 76 , 263 )
129
143
( 94 , 460 )
184
195
( 82 , 318 )
147
157
( 71 , 211 )
107
121
censoring rate: 0.61 ~ 0.65
( 65 , 277 )
122
128
( 91 , 416 )
200
193
( 76 , 310 )
160
154
( 68 , 243 )
133
125
( 77 , 277 )
124
141
( 66 , 218 )
102
114
censoring rate: 0.66 ~ 0.71
( 84 , 345 )
187
177
( 72 , 288 )
144
142
( 61 , 205 )
113
118
( 89 , 422 )
201
194
( 77 , 370 )
165
155
( 62 , 217 )
114
128

para

Ewell
nonpara
95% CI

( 125 , 640 )
( 89 , 435 )
( 76 , 263 )
( 93 , 460 )
( 82 , 317 )
( 69 , 210 )

210
162
130
185
149
108

249
194
143
195
157
121

( 126 , 640 )
( 89 , 435 )
( 76 , 263 )
( 93 , 460 )
( 82 , 317 )
( 70 , 210 )

( 65 , 277 )
( 91 , 415 )
( 76 , 308 )
( 68 , 241 )
( 76 , 276 )
( 65 , 214 )

123
200
161
133
125
104

128
193
154
125
141
114

( 65 , 277 )
( 91 , 415 )
( 76 , 309 )
( 68 , 242 )
( 77 , 276 )
( 65 , 215 )

( 84 , 345 )
( 72 , 287 )
( 61 , 205 )
( 88 , 418 )
( 76 , 368 )
( 62 , 217 )

178
143
119
194
156
129

187
144
113
201
165
114

( 84 , 345 )
( 72 , 287 )
( 61 , 205 )
( 88 , 418 )
( 76 , 368 )
( 62 , 217 )

Settings used in the simulation study for Weibull distribution are listed as follows
The population follows the mixture cure model with the Weibull distribution, which can
be written as
𝑆0 (𝑡) = 𝜋0 + (1 − 𝜋0 )𝑒 −(𝜆0 𝑡)

𝑘

𝑆̅(𝑡) = exp(−(𝜆0 𝑡)𝑘 𝑒 𝛽𝑥̅ )
1) an accrual period of 1 year and a follow up time of 4 years;
2) Baseline scale parameter is set at 𝜆0 = 0.1, 0.2, 0.5., which corresponding to the
mean survival time of baseline as 10, 5, 2. Shape parameter is 2.
3) For each 𝜆0 , cure rate for control arm 𝜋0 is set at 0.2 and 0.1.
4) 𝑒 −𝛽0 is at (1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8), 𝑒 𝛾0 is at (0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0).
Settings used in the simulation study for lognormal distribution are listed as follows:
The population follows the mixture cure model with the lognormal distribution, which can
be written as
𝑆0 (𝑡) = 𝜋0 + (1 − 𝜋0 )(1 − 𝑝𝑛𝑜𝑟𝑚 (

𝑙𝑛𝑡 − µ0
))
𝜎0

𝑆̅(𝑡) = exp(−(𝜆0 𝑡)𝑘 𝑒 𝛽𝑥̅ )
1) an accrual period of 1 year and a follow up time of 20 years;
2) Baseline scale parameter is set at 𝜎0 = 2, 2.5, 3.5., which corresponding to the
mean survival time of baseline as 5, 4, 0.286. Shape is 0.1.
3) For each 𝜆0 , cure rate for baseline 𝜋0 is set at 0.4 and 0.5.
4) 𝑒 −𝛽0 is at (1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8), 𝑒 𝛾0 is at (0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0).
Effects of follow up period are investigated on the Weibull distribution as an
example, the settings are listed as follows:
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1) an accrual period of 1 year and baseline scale parameter is set at 𝜆0 = 2,
2) follow up period is set at 𝜏𝑓 = 5, 10, 15, 25.
3) 𝜋0 is set at 0.4, and shape parameter 𝑘 = 0.1.
4) 𝑒 −𝛽0 is at (1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8), 𝑒 𝛾0 is at (0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0).

3.3.2 SIMULATION RESULTS
For the exponential distribution, the mean survival time is calculated as 1⁄𝜆 .
0
Corresponding to 𝜆0 = (0.1, 0.25, 0.75), mean censoring rate is attained at (0.82, 0.64,
0.41) for 𝜋0 = 0.2, and at (0.78, 0.56, 0.28) for 𝜋0 = 0.1. As shown in Figure 3.7, if
looking at the left upper panel for case of relatively high censoring rate (censr = 0.82), the
empirical power calculated by Wang’s method significantly different from the nominal
power. The Ewell method worked very well, in which the largest deviation is only 4% from
the nominal power. With the censoring rate decreasing to 0.64 and 0.41, Wang method
performs better, while the Ewell maintains good performance in all scenarios. In censoring
rate of 0.41, all the cases got good estimation, with nearly all deviation of empirical power
from nominal power smaller than 3%. Similar trend has been observed for the three graphs
in right panel, where 𝜋0 = 0.1.
For the Weibull distribution, mean survival time is calculated as

𝛤(1+1/𝑘)
𝜆0

. As the

result, larger 𝜆0 will lead to shorter mean survival time, and thus higher censoring rate. For
𝜋0 = 0.2, corresponding to 𝜆0 = (0.1, 0.25, 0.75), mean censoring rate is achieved at
(0.91, 0.71, 0.37). Similar trend is observed for Weibull distribution, as for exponential
distribution in Figure 3.8. The Ewell method shows superior performance over the Wang
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method in relative high and medium censoring rate (censr = 0.91 and 0.71). While for low
censoring rate (censr = 0.37), both of the methods perform well, nearly all the deviation of
empirical power from the nominal power is less than 2%. Similar trend is observed for
𝜋0 = 0.1. In which, the mean censoring rate is (0.89, 0.65, 0.23).

Figure 3.7 Comparing two methods for exponential distribution, for nonbinary covariate
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Effects of follow up period 𝜏𝑓 is studied for Weibull distribution. By adjusting 𝜏𝑓
in the range of (4, 10, 15, 25), actual mean censoring rate is achieved at (0.91, 0.64, 0.47,
0.36). Similar as the case for Weibull distribution in binary case, by increasing 𝜏𝑓 , more
events could be detected, and thus lower censoring rate will be achieved.

Figure 3.8 Comparing two methods for Weibull distribution, for nonbinary covariate
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As shown in Figure 3.9, the Ewell method performs significantly better than the
Wang method when 𝜏𝑓 is 4 and 10. When extending 𝜏𝑓 to 15, Ewell method becomes only
slightly better than Wang method. When 𝜏𝑓 reaches 25, corresponding to a censoring rate
of 0.36, we couldn’t distinguish between the two methods, with all the deviation of
empirical power from the nominal power less than 4%.
Different from the exponential and Weibull distribution, increasing 𝜆0 results in
increasing censoring rate in lognormal distribution, as shown in Figure 3.10. For 𝜋0 = 0.4,
by varying 𝜎0 at (2, 2.5, 3.5), mean censoring rate is acquired at (0.63, 0.66, 0.70). As seen
from here, censoring rate is relatively stable while changing 𝜎0 . With all the settings here,
Ewell method performs significantly better than the Wang method. Similar trend is
observed for 𝜋0 = 0.5 as for 𝜋0 = 0.4.

Figure 3.9 Comparing the Wang and Ewell methods for Weibull distribution, for
nonbinary covariate, adjusting follow up period
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Figure 3.10 Comparing the Wang and Ewell methods for Lognormal distribution, for
nonbinary covariate
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CHAPTER 4 REAL DATA APPLICATION AND POWER ANALYSIS
The components needed for the sample size calculation package include: sample
size (power), censoring distribution (accrual period, follow up time, accrual distribution),
and components specific for the mixture cure model (hazard ratio 𝑒 𝛽0 , odds ratio (𝑒 𝛾0 ,
𝜋1 , 𝜋0 ), survival distribution). In our package, there are two syntaxes for specifying the
survival distribution: one is parametric syntax assuming the Exponential (Weibull, or
Lognormal) survival distribution with all the parameters defined; the other is
nonparametric syntax using the known dataset to estimate all the necessary parameters
through smcure package. In this chapter, we will illustrate specifically how to apply the
package in both parametric and nonparametric approaches.
In section 4.1, we introduce the parametric sample size estimation by using a
specific example under Weibull distribution. Both the syntax and output interface is
demonstrated. Especially for output, it’s shown that the function is flexible with the option
“method” that can either output the result from Schoenfeld method only, or can output the
results from all three methods at the same time. Section 4.2 illustrates the application of
the package to a well-known data set Eastern Cooperative Oncology Group trial e1684, as
well as the calculation for cure rates. Section 4.3 studies the association between the power
and the sample size by power curve analysis. Section 4.4 conducts the power curve analysis
under various hazards ratios, as well as the power curve analysis under various odds ratios.
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4.1 PARAMETRIC SAMPLE SIZE ESTIMATION
The package assumed that both arms follow the same distribution, such as
exponential, Weibull or lognormal. For example, if a survival trial follows a uniform
accrual with an accrual period of 2 years and a follow-up period of 5 years, with equal
allocation of patients in each arm (𝑝 = 0.5). The mean life of uncured patients is 3 years
for control arm and 4 years for treatment arm. It’s assumed that both arms follow the
Weibull distribution with 𝑘 = 2. Cure rates are 𝜋0 = 0.2 and 𝜋1 = 0.3 for the control and
treatment arm, respectively. In order to detect a 33% improvement in the mean survival
time from 3 to 4 years, at 95% significance level and 90% power, the estimated sample
size can be acquired by the following code:

The output is as follows:

As shown from the above result, a sample size of 411 patients will be needed to
achieve a power of 90% based on PH mixture cure model. While the sample size estimate
d from the standard PH model is 551, which apparently underestimates the power.
If the “method” option is set as “all”, results from all the three methods will be
displayed together as follows,
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4.2 REAL DATA ANALYSIS
The application of our sample size calculation package to the real data is illustrated
with the dataset from Eastern Cooperative Oncology Group trial e1684 [18]. Note that our
intension here is not to re-design the trial but to show the sample size requirement under
the mixture cure model when the hazard ratio and cure rates are estimated from the dataset
itself. The ECOG e1684 is a two-arm phase III clinical trial comparing high-dose interferon
alpha-2b with an observation arm. The primary endpoint was relapse-free survival (RFS),
with RFS defined as the time from randomization until progression of the tumor or death.
There are a total of 286 patients enrolled and the total study time is 7 years, with an accrual
period of 4 years and a follow-up period of 3 years. As seen from the Kaplan Meier survival
curve, even in the end of the study (not shown here), the survival probability can still be as
high as about 0.2. So in order to account for this curable part, mixture cure model should
be applied here.
To do nonparametric estimation, only power, alpha, accrualtime, followuptime, p,
accrualdist and data need to be specified, with the hazard ratio and cure rates being directly
estimated from the dataset by smcure package. The following code is used to obtain the
sample size:
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The output is as follows:

The data are first fitted by recalling the smcure R package with the treatment as a
covariate. The log(ℎ𝑎𝑧𝑎𝑟𝑑𝑟𝑎𝑡𝑖𝑜)𝛽0 is estimated as −0.164 from the smcure package.
The coefficient from logistic regression model for modeling the cured part is 1.285 and 0.546, which results in the cure rates for the observation arm and treatment arm calculated
as follows:
𝜋̂0 = 1 − 𝑒 1.285 ⁄(1 + 𝑒 1.285 ) = 0.217
𝜋̂1 = 1 − (𝑒 1.285−0.546 )⁄(1 + 𝑒 1.285−0.546 ) = 0.323
And thus to achieve 80% power, a sample size of 459 is required based on the estimates
from the PH mixture cure model, while only 255 is required if ignoring the cured part. As
is clearly seen, under this set of parameters, the cure fraction will lead to an underpowered
trial.
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4.3 POWER ANALYSIS
Besides the sample size calculation, the package can provide power analysis if the
sample sizes are given. Using the same setting as in 4.1, the power of the sample size of
100, 150, 200, 250, 300, 350, 400, 450 and 500, can be obtained by using the following
code:

As seen from the Figure 4.1, with the increase of sample size from 100 to 500, the power
will increase from 0.36 to 0.95 for PH mixture cure model, and from 0.28 to 0.87 for
standard PH model. Comparing the results between PH mixture cure model and standard
PH model, the power is underestimated with ignoring the cure fraction.
Figure 4.2. shows how to calculate the power using the e1684 data. For both of the
models, the calculated power increase with increasing sample size. However, ignoring the
cure fraction leads to overestimating the power.

4.4 POWER ANALYSIS FOR STUDYING EFFECTS OF HAZARDRATIO AND
ODDSRATIO
Power analysis is conducted to study the effects of the hazard ratio and odds ratio.
For example, a survival trial will follow a uniform accrual with an accrual period of 3 years
and a follow-up period of 4 years with equal allocation of patients in each arm (𝑝 = 0.5).
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Figure 4.1 Power analysis for parametric estimation

Figure 4.2 Power analysis for nonparametric estimation
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The mean life of uncured patients in the control arm will be 2 years. Both arms follow the
Exponential distribution and cure rate for control arm is 0.1. Oddsratio is set at 1.5. Hazard
ratio is varied at (0.56, 0.59, 0.63, 0.67, 0.71, 0.77, 0.83). Powers under different sample
sizes (100, 200, 300, 400, 500) are plotted in Figure 4.3. Generally, power decreases with
increasing hazard ratio. Higher hazard ratio indicates smaller difference between two arms’
uncured parts. And thus it will result in the lower power in detecting the difference between
the two arms. With the same hazard ratio, power will increase with the increase of the
sample size.

Figure 4.3 Effects of hazardratio on power under different sample sizes
The same setting is used to study the effects of oddsratio on power. The hazard ratio
is set at 0.83, while the oddsratio is varied at (2.718, 2.460, 2.226, 2.014, 1.822, 1.649,
1.492). Similarly, powers under different sample sizes (100, 200, 300, 400, 500) are plotted
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in Figure 4.4. Power increases with increasing odds ratio. Larger odds ratio means more
significant differences between the cure rates of two arms, and thus easier to be
differentiated. With the same odds ratio, increasing sample size will increase the power.

Figure 4.4 Effects of odds ratio on power under different sample sizes
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CHAPTER 5 SUMMARY AND CONCLUSIONS
The development of modern medical technology has substantially improved cure
rates for many fatal and chronic diseases. The mixture cure model is more appropriate to
be applied to this type of study in order to account for the cured fractions among patients.
The two components of the mixture cure model can model the cured and uncured
proportions separately and simultaneously.
Sample size calculation is crucial for designing randomized controlled clinical trials
in survival analysis. The current sample size calculation method for PH mixture cure model
naturally extends the sample size formula for standard PH model by allowing a cure
fraction. However, this formula has limitations in calculating the probability of death,
which is currently contributed only from the control arm, and this may underestimate or
overestimate the required sample size. In the thesis, we have investigated the two modified
versions of the sample size calculations for the PH mixture cure model. First we propose
two methods for correcting the calculation of probability of death, by acquiring the numeric
mean and geometric mean of the probability of death based on both control arm and
treatment arm. Extensive simulation study has shown that the two proposed methods
performs significantly better than the WANG’s method under various scenarios, when the
study has the relatively high and medium censoring rate. There’re no significant differences
between the two proposed methods.
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Secondly, the method proposed by Wang has the parametric assumption on survival
function under the exponential and Weibull distribution. We extend all three methods to
the cases with the survival function under lognormal distribution. A simulation study has
illustrated that the two proposed methods performs much better than the Wang method in
the scenarios of relative high and medium censoring rate under lognormal distribution,
similar as exponential and Weibull distribution. When the censoring rate is low, all three
methods has good estimation for the required sample size. All the above proposed methods
and extensions have been implemented in the R package. The method has been further
applied to the melanoma dataset from the ECOG phase III clinical trial e1684. The power
curve analysis has been conducted to demonstrate the application of the proposed methods.
Thirdly, the sample size calculation for PH mixture cure model has been extended
to the nonbinary (continuous) covariate cases under Wang method and Ewell method. The
performances based on two approaches are evaluated by the comprehensive simulations
and we also observe the preferred performance under the Ewell method. The function has
been developed under this case and more verification needed before releasing this function
as a R package.
In the future, there are many potential extensions and research directions for the
sample size calculation under the mixture cure models. For example, it is common to see
more than one treatment option in clinical trial. The sample size formula has been extended
to the multi-arm cases [19] and it is possible to adapt similar approach to the PH mixture
cure model for multi-arm covariates. Other challenging and interesting topics include
developing the sample size calculation under the time varying coefficient structure. There
are some other common scenarios seen in clinical trial, such as loss to follow-up and
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noncompliance such as cross over effects [20, 21], which can also be considered applied
to the sample size calculation in PH mixture cure model to improve the accuracy of sample
size and power calculation.
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